BamSEC and AlphaSense Join Forces
Learn More

Momenta Pharmaceuticals Inc

Formerly NASDAQ: MNTA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 8 pages Anthony Manning Chief Scientific Officer by Email Delivery Re: Retention Agreement Dear Dr. Manning
12/34/56
EX-10.2
from 8-K 6 pages August 19, 2020 Young Kwon Chief Financial and Business Officer by Email Delivery Re: Retention Agreement Dear Dr. Kwon
12/34/56
EX-10.1
from 8-K 9 pages Santiago Arroyo Chief Medical Officer by Email Delivery Re: Retention Agreement Dear Dr. Arroyo
12/34/56
EX-10.2
from 10-Q 29 pages Agreement on Profit Based Settlement and Enoxaparin Transfer
12/34/56
EX-10.1
from 10-Q 33 pages Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan (As Amended and Restated) Article 1. Purpose
12/34/56
EX-10.3.6
from 10-K 5 pages Amendment No. 6 to the Collaboration and License Agreement
12/34/56
EX-10.43
from 10-K 26 pages Settlement Agreement
12/34/56
EX-10.1
from 10-Q 20 pages Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan (As Amended and Restated) Article 1. Purpose
12/34/56
EX-10.1
from 8-K 9 pages Material contract
12/34/56
EX-10.4
from 10-Q 12 pages Executive Employment Agreement
12/34/56
EX-10.3
from 10-Q 10 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 12 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 23 pages Executive Employment Agreement
12/34/56
EX-10.41.6
from 10-K 3 pages Fifth Amendment to Lease
12/34/56
EX-10.39
from 10-K 8 pages Employment Agreement
12/34/56
EX-10.38
from 10-K 8 pages Employment Agreement
12/34/56
EX-10.37
from 10-K 6 pages Agreement and General Release
12/34/56
EX-10.36
from 10-K 6 pages Agreement and General Release
12/34/56
EX-10.35
from 10-K 6 pages Agreement and General Release
12/34/56
EX-10.2
from 10-Q 7 pages Sixth Amendment to and Partial Termination of Lease Agreement
12/34/56